Our experiments with concomitant embryonic inactivation of Robo2 and mutant Kras activation (KC_Robo2F/F) followed by chronic pancreatitis show no additional phenotypic changes compared to controls. This evidence concerns the gene ROBO2 and chronic pancreatitis.